Aster Capital Management (Difc) LTD Arrowhead Pharmaceuticals, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 883 shares of ARWR stock, worth $18,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
883Holding current value
$18,905% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
91.2MCall Options Held
130KPut Options Held
401K-
Black Rock Inc. New York, NY15.7MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$262 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$190 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$136 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$105 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.27B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...